NO174733C - Fremgangsmåte ved fremstilling av pulmonar surfaktant - Google Patents

Fremgangsmåte ved fremstilling av pulmonar surfaktant

Info

Publication number
NO174733C
NO174733C NO881515A NO881515A NO174733C NO 174733 C NO174733 C NO 174733C NO 881515 A NO881515 A NO 881515A NO 881515 A NO881515 A NO 881515A NO 174733 C NO174733 C NO 174733C
Authority
NO
Norway
Prior art keywords
pulmonary surfactant
preparation
surfactant
adul
irds
Prior art date
Application number
NO881515A
Other languages
English (en)
Other versions
NO881515D0 (no
NO174733B (no
NO881515L (no
Inventor
Bengt Robertson
Tore Curstedt
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO881515D0 publication Critical patent/NO881515D0/no
Publication of NO881515L publication Critical patent/NO881515L/no
Publication of NO174733B publication Critical patent/NO174733B/no
Publication of NO174733C publication Critical patent/NO174733C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
NO881515A 1987-04-08 1988-04-07 Fremgangsmåte ved fremstilling av pulmonar surfaktant NO174733C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8720032A IT1203873B (it) 1987-04-08 1987-04-08 Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e

Publications (4)

Publication Number Publication Date
NO881515D0 NO881515D0 (no) 1988-04-07
NO881515L NO881515L (no) 1988-10-10
NO174733B NO174733B (no) 1994-03-21
NO174733C true NO174733C (no) 1994-06-29

Family

ID=11163272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881515A NO174733C (no) 1987-04-08 1988-04-07 Fremgangsmåte ved fremstilling av pulmonar surfaktant

Country Status (22)

Country Link
US (1) US5024995A (no)
EP (1) EP0286011B1 (no)
JP (1) JP2700323B2 (no)
AT (1) ATE99949T1 (no)
AU (1) AU619462B2 (no)
CA (1) CA1320440C (no)
DE (2) DE3886970T2 (no)
DK (1) DK172921B1 (no)
EG (1) EG19626A (no)
ES (1) ES2004856T3 (no)
FI (1) FI92905C (no)
GR (1) GR890300026T1 (no)
HK (1) HK1007103A1 (no)
HU (1) HU211950A9 (no)
IE (1) IE61384B1 (no)
IT (1) IT1203873B (no)
MY (1) MY103260A (no)
NO (1) NO174733C (no)
NZ (1) NZ224146A (no)
PH (1) PH25300A (no)
PT (1) PT87188B (no)
ZA (1) ZA882416B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
KR100218862B1 (ko) * 1990-05-18 1999-09-01 아사이 이페이 천식 치료제
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
ES2124260T3 (es) * 1991-05-03 1999-02-01 Alliance Pharma Respiracion liquida parcial de fluorocarbonos.
ES2118836T3 (es) * 1991-11-14 1998-10-01 Alliance Pharma Procedimiento y aparato de ventilacion parcial con liquidos usando fluorocarburos.
IT1255967B (it) * 1992-11-27 1995-11-17 Chiesi Farma Spa Procedimento per la purificazione di materiale surfattante polmonare naturale con l'impiego di fluidi supercritici
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
CO5021218A1 (es) * 1994-12-29 2001-03-27 Ct Nac De Sanidad Agropecuaria Surfactante pulmonar natural porcino
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
WO1997029738A1 (en) * 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Methods and compositions for treating eustachian tube dysfunction by inhalation
WO2001019392A1 (en) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
DE50214446D1 (de) 2001-10-11 2010-07-01 Nycomed Gmbh Neue verwendung von lungensurfactant
CA2575513C (en) 2004-08-06 2014-09-16 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
EP1841458B9 (en) 2005-01-06 2012-12-12 Discovery Laboratories, Inc. Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
GB2426703B (en) * 2005-05-31 2007-09-19 Malvern Cosmeceutics Ltd Compositions
BRPI0717177A2 (pt) * 2006-09-19 2013-10-08 Discovery Lab Inc Formulações de tensoativo pulmonar e métodos para promoção de eliminação de muco
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
DE102007025898A1 (de) * 2007-06-01 2008-12-04 Matthias W. Dr. Amrein Behandlung von Surfactanten
WO2010068754A2 (en) 2008-12-10 2010-06-17 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
JP2020526585A (ja) * 2017-07-07 2020-08-31 リポバイオメド コーポレイションＬｉｐｏｂｉｏｍｅｄ Ｃｏｒｐｏｒａｔｉｏｎ 火傷及び褥瘡の緩和及び治療用組成物
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants
EP4366691A1 (en) 2021-07-05 2024-05-15 Chiesi Farmaceutici S.p.A. Process for the preparation of a pulmonary surfactant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
US4312860A (en) * 1980-10-24 1982-01-26 Regents Of The University Of California Lung surfactant compositions
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤
JPS58222022A (ja) * 1982-06-21 1983-12-23 Teijin Ltd 合成肺表面活性剤及びそれを有効成分とする呼吸窮迫症候群治療剤
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
BG49073A1 (en) * 1983-12-08 1991-08-15 Dresden Arzneimittel Remedy for treatment of asthmatic syndrome caused by lack of surface- active substance and method for obtaining it
JPS6165821A (ja) * 1984-09-07 1986-04-04 Tokyo Tanabe Co Ltd 合成サ−フアクタント及びそれを有効成分とする肺表面活性物質喪失性無気肺の治療剤
FR2586587B1 (fr) * 1985-08-30 1987-10-23 Adir Nouveaux surfactants artificiels, leur preparation et les compositions pharmaceutiques qui les contiennent.
WO1987006943A1 (en) * 1986-05-06 1987-11-19 Children's Hospital Medical Center Pulmonary hydrophobic surfactant-associated protein of 6,000 daltons molecular weight and multimers thereof

Also Published As

Publication number Publication date
IT1203873B (it) 1989-02-23
DE3886970T2 (de) 1994-05-26
EP0286011A3 (en) 1990-02-07
DE3886970D1 (de) 1994-02-24
NO881515D0 (no) 1988-04-07
GR890300026T1 (en) 1989-04-12
FI881508A0 (fi) 1988-03-30
PH25300A (en) 1991-04-30
PT87188B (pt) 1992-07-31
EG19626A (en) 1995-09-30
FI92905B (fi) 1994-10-14
NZ224146A (en) 1991-06-25
DK190088A (da) 1988-10-09
NO174733B (no) 1994-03-21
FI881508A (fi) 1988-10-09
NO881515L (no) 1988-10-10
FI92905C (fi) 1995-01-25
ATE99949T1 (de) 1994-01-15
HK1007103A1 (en) 1999-04-01
ES2004856T3 (es) 1994-12-16
EP0286011B1 (en) 1994-01-12
PT87188A (pt) 1988-05-01
ZA882416B (en) 1988-09-28
DK172921B1 (da) 1999-10-04
JPS6463526A (en) 1989-03-09
JP2700323B2 (ja) 1998-01-21
DE286011T1 (de) 1989-03-09
IT8720032A0 (it) 1987-04-08
ES2004856A4 (es) 1989-02-16
IE881008L (en) 1988-10-08
HU211950A9 (en) 1996-01-29
US5024995A (en) 1991-06-18
CA1320440C (en) 1993-07-20
AU1433788A (en) 1988-10-13
IE61384B1 (en) 1994-11-02
MY103260A (en) 1993-05-29
EP0286011A2 (en) 1988-10-12
DK190088D0 (da) 1988-04-07
AU619462B2 (en) 1992-01-30

Similar Documents

Publication Publication Date Title
NO174733C (no) Fremgangsmåte ved fremstilling av pulmonar surfaktant
SE7904010L (sv) Sett att utvinna protein ur vassla
EP0156961A3 (en) Process for preparing highly purified, stroma-free and hepatitis-resisting human and animal haemoglobin solutions
ES2027744T3 (es) Procedimiento de preparacion de un producto lactoserico de alergenicidad reducida.
AU5267493A (en) Process for the recovery of alpha-lactalbumin and beta-lactoglobulin from a whey protein product
EP0311283A3 (en) Process for obtaining concentrates having a high alpha-lactalbumin content from whey
NO874899D0 (no) Fremgangsmaate ved behandling av myseproteiner.
SE8602877L (sv) Extraktionsforfarande for mjolkproteiner, produkter, anvendning av forfarandet och farmaceutiska kompositioner
AU552141B2 (en) Coluble protein product from whey
ZA894181B (en) Amblyommin,a new active substance for anticoagulant therapy
DE3466695D1 (en) Process for the preparation of globin from hemoglobin, and globin obtained in this process
JPS6416795A (en) Production of bovine brain extract
ES8605678A1 (es) Procedimiento de obtencion de gamma-globulina humana a partir de sangre hemolizada procedente de placentas

Legal Events

Date Code Title Description
MK1K Patent expired